| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 口服制剂(元) | 57,799,927.60 | 136,211,600.70 | 69,419,468.57 | 134,063,360.61 | 62,497,359.64 |
| 外用制剂(元) | 15,891,671.18 | 71,090,180.48 | 36,039,452.07 | 53,031,258.45 | 60,574,469.04 |
| 营业成本(元) | |||||
| 口服制剂(元) | 23,038,644.53 | 43,675,380.76 | 20,615,756.36 | 36,219,097.93 | 18,757,151.09 |
| 外用制剂(元) | 10,849,848.76 | 19,530,304.31 | 6,583,812.45 | 17,534,824.29 | 17,311,074.65 |
| 毛利(元) | |||||
| 口服制剂(元) | 34,761,283.07 | 92,536,219.94 | 48,803,712.21 | 97,844,262.68 | 43,740,208.55 |
| 外用制剂(元) | 5,041,822.42 | 51,559,876.17 | 29,455,639.62 | 35,496,434.16 | 43,263,394.39 |
| 毛利率(%) | |||||
| 口服制剂(%) | 60.14 | 67.94 | 70.30 | 72.98 | 69.99 |
| 外用制剂(%) | 31.73 | 72.53 | 81.73 | 66.93 | 71.42 |
| 收入构成(%) | |||||
| 口服制剂(%) | 78.43 | 65.71 | 65.83 | 71.66 | 50.78 |
| 外用制剂(%) | 21.57 | 34.29 | 34.17 | 28.34 | 49.22 |
| 毛利构成(%) | |||||
| 口服制剂(%) | 87.33 | 64.22 | 62.36 | 73.38 | 50.27 |
| 外用制剂(%) | 12.67 | 35.78 | 37.64 | 26.62 | 49.73 |